Nathan J. Dowden, President & COO: Entrada Therapeutics TRDA Planned sale · Filed 03/09

Trade details

Type: Planned sale notice
Stock: Entrada Therapeutics TRDA
Person: Nathan J. DowdenPresident & COO
Planned sale date: 26/03/09
Filed: 26/03/09

More to sell after $249.2K in 3 months

Entrada Therapeutics trades, last 26 weeks

What else happened in Entrada Therapeutics around then

Filed or reported within 30 days of the trade day · 02/07~04/08

Nathan J. Dowden's recent trades

Nathan J. DowdenPresident & COO
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$230K
15,000 sh
$230K
Filed 05/04
Traded 05/04
Nathan J. DowdenPresident & COO
Planned sale10b5-1 planEntrada Therapeutics
Planned sale10b5-1 plan
Entrada Therapeutics
TRDA
$217.5K
15,000 sh
$217.5K
Filed 05/04
Traded 05/04
Nathan J. DowdenPresident & COO
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$155.2K
11,894 sh
$155.2K
Filed 03/11
Traded 03/10
Nathan J. DowdenPresident & COO
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$40.6K
3,116 sh
$40.6K
Filed 03/11
Traded 03/09
Nathan J. DowdenPresident & COO
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$13.6K
847 sh
$13.6K
Filed 24/09/30
Traded 24/09/26

Nathan J. Dowden, COO — plans to sell 15,010 sh of Entrada Therapeutics TRDA · $188.8K · around 03/09 · 10b5-1 plan | Whalegun